Leerink Partnrs Issues Pessimistic Forecast for EW Earnings
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Edwards Lifesciences in a research report issued on Wednesday, February 12th. Leerink Partnrs analyst M. Kratky now expects that the medical research company will earn $0.58 per share for the quarter, […]
